Shanghai Pharmaceuticals Holding Patents – Key Insights and Stats

Shanghai Pharmaceuticals Holding has a total of 1154 patents globally, out of which 732 have been granted. Of these 1154 patents, more than 63% patents are active. China is where Shanghai Pharmaceuticals Holding has filed the maximum number of patents, followed by United States of America and Europe, it has generated an annual revenue of $3.73 billion in the year 2020. Parallelly, China seems to be the main focused R&D center and is also the origin country of Shanghai Pharmaceuticals Holding.

Shanghai Pharmaceuticals Holding was founded in the year 1994. Company is doing business in developing and distributing pharmaceutical products. As of January 2022, Shanghai Pharmaceuticals Holding has a market cap of $5.9 Billion.

Do read about some of the most popular patents of Shanghai Pharmaceuticals Holding which have been covered by us in this article and also you can find Shanghai Pharmaceuticals Holding’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Shanghai Pharmaceuticals Holding’s patent portfolio.

How many patents does CEO of Shanghai Pharmaceuticals Holding have?

The CEO, Da Wei Liu has 0 patents.

How many patents does Shanghai Pharmaceuticals Holding have?

Shanghai Pharmaceuticals Holding has a total of 1154 patents globally. These patents belong to 945 unique patent families. Out of 1154 patents, 733 patents are active.

How many Shanghai Pharmaceuticals Holding patents are Alive/Dead?

Worldwide Patents

Shanghai Pharmaceuticals Holding Worldwide Legal Trends

Patent Families

Shanghai Pharmaceuticals Holding Patent Portfolio

How Many Patents did Shanghai Pharmaceuticals Holding File Every Year?

Shanghai Pharmaceuticals Holding Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantShanghai Pharmaceuticals Holding Applications FiledShanghai Pharmaceuticals Holding Patents Granted
20112637
20126525
20137735
20144641
20156447
20168146
20179140
201810544
201911648
202011189
202142103
20222

How Many Patents did Shanghai Pharmaceuticals Holding File in Different Countries?

Shanghai Pharmaceuticals Holding Worldwide Filing in Top 10 Countries

Countries in which Shanghai Pharmaceuticals Holding Filed Patents

CountryPatents
China948
United States Of America33
Europe20
Japan19
Canada9
Germany7
Australia6
Korea (South)5
Hong Kong (S.A.R.)5
United Kingdom4
Taiwan4
Brazil4
Israel4
Spain3
Denmark3
Portugal2
India2
Russia2
Italy1
Hungary1
Poland1
Austria1
South Africa1
Philippines1
Slovenia1
Mexico1

Where are Research Centers of Shanghai Pharmaceuticals Holding Patents Located?

Shanghai Pharmaceuticals Holding R&D Centers

10 Best Shanghai Pharmaceuticals Holding Patents

WO2014086284A1 is the most popular patent in the Shanghai Pharmaceuticals Holding portfolio. It has received 53 citations so far from companies like Kala Pharmaceuticals, Shilpa Medicare and Array Biopharma.

Below is the list of 10 most cited patents of Shanghai Pharmaceuticals Holding:

Publication NumberCitation Count
WO2014086284A153
US6187314B135
CN103304572A32
CN102875537A27
CN101427764A22
CN1977841A22
WO2013170774A121
CN1520797A16
WO2015018356A116
CN103654981A15

What Percentage of Shanghai Pharmaceuticals Holding US Patent Applications were Granted?

Shanghai Pharmaceuticals Holding (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 91.67%.

Below are the key stats of Shanghai Pharmaceuticals Holding patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Shanghai Pharmaceuticals Holding?

Law FirmTotal ApplicationSuccess Rate
Birch Stewart Kolasch & Birch Llp5100.00%
Pilloff Passino & Cosenza Llp5100.00%
Houston Beshining Law Office Pllc1100.00%
Nixon & Vanderhye Pc10.00%
Oliff Plc1100.00%

Innovative medications, chemical drugs, traditional Chinese medicines, and rare disease drugs are among Shanghai Pharmaceuticals Holding’s offerings. The cardiovascular system, digestive tract, and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system, and respiratory system are all areas where the company’s products are used. Medical logistics and warehousing services are also provided by the company. The company sells its products both in the domestic markets and internationally.

EXCLUSIVE INSIGHTS COMING SOON!

What are Shanghai Pharmaceuticals Holding key innovation segments?

What Technologies are Covered by Shanghai Pharmaceuticals Holding?

The chart below distributes patents filed by Shanghai Pharmaceuticals Holding in different countries on the basis of the technology protected in patents. It also represents the markets where Shanghai Pharmaceuticals Holding thinks it’s important to protect particular technology inventions.

R&D Focus: How Shanghai Pharmaceuticals Holding search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Shanghai Pharmaceuticals Holding?

Updated on February 22, 2022

Was this article helpful?

Leave a Comment